Showing results (51-60 of 355) with videos related to

Sort By:
Pageof 36
Der Nervenarzt|November 2, 2001
[Multiple sclerosis. Chlamydia hypothesis in debate]T Derfuss, R Hohlfeld, E Meinl
Immunology Letters|October 1, 1994
Constitutive and cytokine-induced production of interleukin-6 by human myoblastsE Bartoccioni, D Michaelis, R Hohlfeld
Neuroscience|October 14, 2008
Neuro-immune crosstalk in CNS diseasesM Kerschensteiner, E Meinl, R Hohlfeld
Der Internist|February 28, 2015
[Immunotherapies for multiple sclerosis : review and update]J Havla, T Kümpfel, R Hohlfeld
Drug Safety|December 12, 2001
Risk-benefit assessment of glatiramer acetate in multiple sclerosisT Ziemssen, O Neuhaus, R Hohlfeld
Der Nervenarzt|September 24, 2002
[Antegren (natalizumab). A promising new approach to therapy of multiple sclerosis]T Kümpfel, N Heydari, R Hohlfeld
Human Pathology|July 1, 1986
Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathiesA G Engel, K Arahata
Brain Research|November 18, 1996
Block of the endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine, and albuterolM Milone, A G Engel
European Journal of Biochemistry|May 15, 1985
Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscleS Zierz, A G Engel
Science (New York, N.Y.)|March 2, 1973
Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndromeA G Engel, C Angelini
Pageof 36